← Company intelligence

Robot maker · early

Channel Robotics

Corporate marketmedicalCurated record

UC San Diego spinout (IGE portfolio) building a handheld, AI-enabled endoscopic robotic platform that adds robotic articulation and precision instrument control through existing flexible endoscopes, avoiding large capital-intensive surgical robot systems. Patented miniaturized continuum-robot instruments provide AI-driven articulation beyond human wrist dexterity for endoluminal procedures. Co-founded by physician-scientist Philip Weissbrod and roboticist Michael Yip (UCSD ARClab). NSF SBIR-backed; FDA submission targeted for 2027 with commercial launch after clearance.

HeadquartersDel Mar, US
Founded2023
Corporate funding$6M
Team1-10
Deployments0
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeed
FoundersPhilip Weissbrod (Co-founder & CEO), Michael Yip (Co-founder)
Regions servedUS
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Channel handheld endoscopic robot

  • Handheld robotic platform delivering robotic precision through existing flexible endoscopes without a capital-intensive console

    Miniaturized tendon-driven robotic instruments and AI-driven articulation controlled by the operating endoscopist

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordTrue VenturesDefined VCOld Line Capital Partners
TL

Company timeline

Milestones and announcements

2026-06-20Raised $2.5M Seed+ led by True Ventures ($4.6M total) to advance endoscopic robotics platformcitybiz
SC

Source ledger

4 unique public sources